With new update in hand, Intellia CEO now claims one-time HAE gene editing treatment 'may be a functional cure'

Lei Lei Wu

News Reporter

In September, Intellia gave a first look into its one-time treatment for hereditary angioedema — a disease that causes severe swelling attacks — that directly edits the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

With new update in hand, Intellia CEO now claims one-time HAE gene editing treatment 'may be a functional cure'

Lei Lei Wu

News Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

With new up­date in hand, In­tel­lia CEO now claims one-time HAE gene edit­ing treat­ment 'may be a func­tion­al cure'

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

With new update in hand, Intellia CEO now claims one-time HAE gene editing treatment 'may be a functional cure'